For those who are postmenopausal and exploring GLP-1s, talk to a clinician about safe, personalized dosing or GLP-1 microdosing options
Retatrutide represents a major step forward in weight loss treatment
Semaglutide injections may be a suitable treatment option for individuals with a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition, like type 2 diabetes or high blood pressure
These injections work by regulating appetite, reducing food intake, and increasing feelings of fullness
GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway
Understanding the relationship between allulose intake and GLP-1 response requires careful consideration of current evidence, FDA guidelines, and how this sweetener compares to established diabetes management strategies